Alert4 days ago 3 min read
Counterfeit GLP-1 vials surge across European borders
Customs seizures of fake semaglutide and tirzepatide have nearly doubled this year.
by Editorial team
The data
European customs agencies report a near-doubling of counterfeit GLP-1 seizures in 2026 versus the same period last year.
Most counterfeits target semaglutide and tirzepatide branded products.
What's in the fakes
Laboratory analysis of seized vials has found incorrect dosages, contaminants, and in some cases, no active ingredient at all.
A subset contained insulin, which can cause severe hypoglycemia.
How to protect yourself
Only buy from licensed pharmacies in your jurisdiction.
Verify packaging, batch numbers, and supplier credentials before use.
